South Korea: Korea Food and Drug Administration (KFDA) [clinicaltrials_resource:549728cc585e854b1cca2745052b1042]
clinicaltrials:NCT00141219Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate [clinicaltrials:NCT00235859]Fexofenadine in Pruritic Skin Disease [clinicaltrials:NCT00261079]clinicaltrials:NCT00278863clinicaltrials:NCT00278876clinicaltrials:NCT00296322Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea [clinicaltrials:NCT00328965]Amisulpride in Schizophrenic Patients [clinicaltrials:NCT00331981]S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer [clinicaltrials:NCT00343668]Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene [clinicaltrials:NCT00444795]A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography [clinicaltrials:NCT00447889]Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00452244]Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) [clinicaltrials:NCT00452634]Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00452803]Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC [clinicaltrials:NCT00452881]Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00453115]Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer [clinicaltrials:NCT00453167]Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer [clinicaltrials:NCT00453323]clinicaltrials:NCT00455858clinicaltrials:NCT00455936Developement of Questionnaire to Evaluate a Regularity of Lifestyle in Type 2 Diabetic Patients [clinicaltrials:NCT00455988]Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS) [clinicaltrials:NCT00480649]Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV [clinicaltrials:NCT00501124]Symbicort SMART (Symbicort Maintenance And Reliever Therapy) [clinicaltrials:NCT00523679]Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer [clinicaltrials:NCT00532285]clinicaltrials:NCT00540124Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy [clinicaltrials:NCT00542165]Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients [clinicaltrials:NCT00558493]Long-term Study With Clevudine [clinicaltrials:NCT00558818]Effects of Early Oral Feeding After Resection of Gastric Cancer [clinicaltrials:NCT00606619]ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder [clinicaltrials:NCT00613067]Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions [clinicaltrials:NCT00637091]Treatment of Vasomotor Symptoms in Korean Post Menopausal Women [clinicaltrials:NCT00651599]Observational Study of Patients With Diabetes Using Levemir® FlexPen® [clinicaltrials:NCT00670683]Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female [clinicaltrials:NCT00679315]clinicaltrials:NCT00723931clinicaltrials:NCT00729482A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED) [clinicaltrials:NCT00732875]Antiangiogenic Factors in Gastric Cancer [clinicaltrials:NCT00735566]Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes [clinicaltrials:NCT00737776]
oversight [clinicaltrials_vocabulary:oversight]
South Korea: Korea Food and Drug Administration (KFDA) [clinicaltrials_resource:549728cc585e854b1cca2745052b1042]
Bio2RDF identifier
549728cc585e854b1cca2745052b1042
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:549728cc585e854b1cca2745052b1042
has dmc [clinicaltrials_vocabulary:has-dmc]
identifier
clinicaltrials_resource:549728cc585e854b1cca2745052b1042
title
South Korea: Korea Food and Drug Administration (KFDA)
@en
type
label
South Korea: Korea Food and Dr ...... 728cc585e854b1cca2745052b1042]
@en